More on IXHL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (1/2/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Incannex Healthcare (NQ:IXHL)
Delayed: 2.99 --0 (-0%)
Prev. Close $2.99  
Open$2.99 
52 Wk High$ 
52 Wk Low$ 
Day High$2.99 
Day Low$2.99 
P/E N/A  
EPS$ 
Volume2,973 


Jul 23, 2026 08:00 AM Incannex begins screening for sleep apnea drug study IHL-42X
Jul 23, 2026 08:00 AM Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea
Jul 23, 2026 07:30 AM Form 8-K Incannex Healthcare Inc. For: Jul 23
Jun 25, 2026 08:00 AM Incannex gets U.S. patent for sleep apnea drug IHL-42X through 2040
Jun 25, 2026 08:00 AM Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea
Jun 25, 2026 07:31 AM Form 8-K Incannex Healthcare Inc. For: Jun 25
Jun 10, 2026 08:02 AM Incannex receives A$6 million R&D tax refund from Australia
Jun 10, 2026 08:00 AM Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility
Jun 10, 2026 08:00 AM Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility
Jun 10, 2026 07:31 AM Form 8-K Incannex Healthcare Inc. For: Jun 10
View All Articles

Entities mentioned with IXHL

View All Entities